Artificial Intelligence Is Propelling the Pharmaceutical Industry by Enabling Smart Drug Discovery Solutions

AI creates growth opportunities in novel therapeutics development by leveraging multi-sourced data, finds Frost & Sullivan

SANTA CLARA, California, Dec. 17, 2018 /PRNewswire

With 97 percent of all drug discovery programs failing, the development of a single new therapeutic involves an average cost of $2.6 billion. The complex industry/academia/government research framework involved in the discovery and development of new therapeutic products makes drug discovery an extremely laborious process. Consequently, more than 60 percent of known diseases remain untreatable. Life sciences companies, meanwhile, are making rapid strides in the fields of gene and cell therapies, omics technologies, and smart molecules approaches, creating an urgent need for advanced, cost- and time-effective technologies that can parse large databases of information to help develop novel therapies.

"Pharmaceutical companies are increasingly recognizing the value of deploying Artificial Intelligence (AI)-based platforms that can leverage data regarding gene mutations, protein targets, signaling pathways, disease events, and clinical trials to find hidden drug-disease correlations," said Cecilia Van Cauwenberghe, Associate Fellow and TechVision Senior Industry Analyst at Frost & Sullivan. "This technology will enable scientists to derive structured and unstructured data from multiple sources as never before. Strategic collaborations with AI-driven companies can help large pharmaceutical companies establish a robust, AI-based pipeline as part of their portfolios and address new therapeutic areas."

AI-driven tools are encouraging companies to develop therapies for severely underserved areas and are also paving the way for precision medicine through a stratified therapeutics discovery and development approach. Collaborations among database holders, AI developers, and drug manufacturers will facilitate the early development of multiple therapeutics, even those focused on treating rare and chronic diseases.

AI-based technology companies are also empowered to make the most of scientific results and learning systems synergy to ensure a successful clinical translation of therapeutic, diagnostic, and theranostic developments. Some of the key applications of AI technologies in pharmaceuticals include:

  • Drug development: Aids in disease modeling, drug design and development, lead identification, and drug repurposing.
  • Candidates' validation: Helps design and run pre-clinical trials, in silico/in vitro/in vivo studies, and investigational new drug (IND) process.
  • Clinical trials: Supports all processes, from designing the trial to patient identification through data collection, analysis, and report generation.
  • Regulatory approval: Facilitates the approval of application and process, labeling, and safety updates.
  • Precision medicine: Accelerates the development of preventive and personalized care, treatment surveillance, and omics adaptive models.

Source:  Frost & Sullivan

Illustration Photo: One of the first steps in drug development and toxicity testing is creating test systems (assays) to evaluate the effects of chemical compounds on cellular, molecular or biochemical processes of interest. Investigators from the biomedical research community submit ideas for assays to National Center for Advancing Translational Sciences researchers, who then assist with high-throughput small molecule screening using a robotic system. (credits: U.S. National Center for Advancing Translational Sciences, National Institutes of Health / Flickr Creative Commons Attribution-NonCommercial 2.0 Generic (CC BY-NC 2.0))

Comments

No comments to display.

Related posts

Toyota Mobility Foundation announces finalists in $4 million global Mobility Unlimited Challenge

The Challenge invited engineers, innovators, and designers from across the world to submit designs for game-changing technologies, incorporating intelligent systems, to improve the mobility and independence of people with lower-limb paralysis. Central to the Challenge is the importance of collaboration with end-users to develop devices which will integrate seamlessly into users’ lives and environments, while being comfortable and easy to use, enabling greater independence and increased participation in daily life.

PRIMA Call for Proposals: Bridging the gap between potential and actual irrigation performance in the Mediterranean

In the Mediterranean basin, water balances and water used for irrigation including irrigation performance is often lower than potential at the farm and at the water users association level. This gap is evident for average performance, but it is particularly important when the dispersion among farmers and their associations is considered. Attaining Sustainable Mediterranean irrigation requires to assess the real water balances in the area of irrigation, amount of water available for irrigation ensuring that water levels are environmentally safe for ecosystems and other needs. Furthermore, optimising irrigation performance requires to combine technological, managerial and governance innovations taking into account the availability, safety and quality of water resources, existing institutional arrangements, as well as crop agronomy planning.
Application Deadline in a month

PRIMA Call for Proposals: Agro-food Value Chain 2019

Proposals should focus on products with high added value, most exposed to fraud and valorise productions that have been discontinued but hold nutritional value and are important for biodiversity conservation. Proposal should also aim at creating trans-national networks of laboratories, validating and harmonizing protocols, sharing open-data on food products of the Mediterranean tradition, providing a robust support for certification and control bodies, and building capacity in key enabling technologies related to authenticity and traceability.
Application Deadline in a month

African Development Bank Group approves $25 million Equity Investment in Fund for Renewable Energy Projects in Africa

ARPF projects will focus on mature technologies including wind, solar PV, small to medium hydro, geothermal and biomass. These would include grid-connected independent power producers (“IPPs”), and decentralized energy projects (commercial & industrial solar, mini-grids and solar home systems companies). The Fund’s strategy is to prioritize projects with a clear timeline to financial close, with emphasis on de-risking early stage greenfield projects.

European call for proposals: Innovative utilisation of aquatic biomass and Novel aquaculture production systems

The proposals should seek to be complementary with or adding to other projects funded under FP7 and Horizon 2020, ERA-NETs, BBI JU or other funding schemes, both ongoing and recently finished. They should reflect awareness of the objectives of running projects in relevant fields to avoid overlap. Proposed projects must demonstrate industry involvement.
Application Deadline in 2 months

European call for proposals: Sustainable and Resilient agriculture for food and non-food systems

Based on the two previous calls, the FACCE SURPLUS partners decided to further advance their successful funding scheme with a third call of the initiative in order to complete the portfolio of projects and filling remaining research and funding gaps. Having in mind the research already conducted in FACCE SURPLUS projects, this call at the end of the initiative aims at further improving collaboration in the area of food and nonfood biomass production and transformation systems.
Application Deadline in 2 months

A Quick Look At The Latest Happenings In The Cloud Integration Market

As an emerging trend of technology the field of cloud Integration is steadily expanding. The global cloud Integration Market is growing approximately at a CAGR of 8% during 2018-2023 and it is expected to grow at a highest CAGR during the forecast period.

A Close Look At The Latest Research Trends Within The 3D Printing Metals Market

3D printing involves the creation of a 3 dimensional object by adding successive layers of a particular material one on top of each other until the overall object has been formed. Metals constitute one of the main materials used for 3D printing.

Call for Applications: Go Green in the City 2019

The Go Green in the City challenge is now entering its 9th year running and our 2019 edition is going to be even bigger, better and bolder! We are looking for students like you from around the world who are willing to put their skills and ideas to the test.
Application Deadline in 4 months